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Abstract
Introduction: Adherence to antiretroviral
medication results in reduced HIV
transmission and improved health outcomes,
yet challenges with medication adherence
remain.
Methods: A Collaborative Care Program
was developed with a community pharmacy
integrating a multi-dose adherence packaging
service. We surveyed program participants to
assess their satisfaction with this program.
Results: All participants reported that the
blister packaging program helped them
miss fewer doses of their ART medication.
Similarly, all agreed that they would
recommend the blister packaging program to
others.
Conclusion: We found an overall positive
sentiment toward the program, that the
program helped with reducing missed doses,
and all patients would recommend the
program to others.

Introduction
Since the beginning of the HIV epidemic,
more than 70 million people have been
infected with the virus, and an estimated
35 million have died. By the end of
2016, approximately 36.7 million people
around the world were living with HIV.1
Antiretroviral therapy (ART) allows for
immune reconstitution in people living with
HIV (PLWH) by suppressing HIV replication
and increasing CD4+ counts. Increased
access to ART has prevented a projected
5.2 million AIDS-related deaths in low- and
middle-income countries from 1995 – 2010.2
Adherence to antiretroviral regimens can
reduce HIV transmission and increase the
patient’s life expectancy.3 However, an
estimated 50% of PLWH fail to take their
medications as prescribed.4 Inconsistent
ART adherence can lead to treatment failure
and drug resistance, increasing the risk for
development of AIDS and AIDS-related
conditions leading to death.5 Reasons for
medication non-adherence vary, including
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inability to afford medications, drug regimen
complexity, poor health literacy, forgetfulness,
impact of co-existing psychiatric conditions,
transportation problems, and social or
self-stigmatization.4 Some strategies to
improve medication adherence include
dose simplification, specialized packaging,
and directly observed therapy.6 There is an
association between patient satisfaction with
health care services and adherence to ART,
and using an integrated specialty pharmacy to
provide refill reminders, medication delivery,
and adherence calls have led to improved
immune markers and viral suppression in
patients living with HIV.7,8
Beginning in 2013, the Nebraska Medicine
HIV Clinic partnered with Elmwood
Pharmacy (a community pharmacy adjacent
to the clinic) to develop a Collaborative
Care Program (CCP). As part of the CCP,
medications are placed in multi-dose
adherence blister packaging which is
dispensed every two weeks. The packages
include the patient’s daily medications
including their ART, with as needed
medications dispensed in separate bottles.
Patients receive two weeks supplies of
medication, unless they live outside the
Omaha metro area, which necessitates mail
delivery of one month’s worth of medication.
Patients are required to return the previous
two packages in order to receive new
packages. This returning of their old packages
enables the pharmacy to keep records of
missed doses and recommend adjustment in
timing of medication dosing based on their
findings.
The patients are referred to the blister
packaging program for a variety of reasons.
Some are visually impaired or require closer
supervision, many are prescribed multiple
medications, and most simply forget to take
their medication. Preliminary data from the
pilot program has demonstrated an impact on
virologic suppression, although patient-related
attitudes and satisfaction with the program
have not previously been assessed.9 This
information could be utilized to improve the
program and further tailor it to our patients,
as it is a valuable adherence tool for PLWH.

Therefore, we aimed to evaluate attitudes
and satisfaction with the blister packaging
program.

Methods
People living with HIV receiving care
at the UNMC HIV Clinic and receiving
medications via blister packaging from the
Elmwood Pharmacy were invited to complete
a survey. How did you develop the survey?
Patients who enrolled in the blister packaging
program from 2013 through December 2018
were invited to participate. Paper surveys
were mailed out to patients’ home address
on file and if not completed/returned by
the time of an in-person visit, the survey
was administered on-site, by telephone, or
by the pharmacy courier. The survey was
administered in Spanish for those patients that
required it.
Data Storage. Study data were collected
and managed using the REDCap electronic
data capture tools hosted at the University of
Nebraska Medical Center. Service and support
is provided by the Research Information
Technology Office (RITO), which is funded
by the Vice Chancellor for Research.
Data Analysis. The descriptive analysis
uses frequencies and percentages to
describe categorical data and medians and
interquartile ranges to describe continuous
data. Given the relatively small size of the
sample, possible associations of patient
demographic and clinical characteristics with
medication adherence, barriers to medication
adherence, and satisfaction with the use of
blister packaging were not evaluated using
hypothesis testing methods.
Ethical approval. This project was reviewed
and approved as minimal risk by the
University of Nebraska Medical Center
Institutional Review Board (607-18-EP).

Results
Forty-four patients met criteria for inclusion.
Twenty-three surveys were completed (52.3%

Graduate Medical Education Research Journal

Table 1.
response rate); eight returned by mail, 13
administered in-person during a clinic visit,
one administered over the phone, and one
returned via a courier. Three patients declined
participation and 18 patients did not respond.
The median number of years living with HIV
and on ART were 16.2 and 8.7, respectively.
The median age of the participants was
54, with almost equal distribution of sex
assigned at birth. The participants were
largely non-Hispanic white (52%) with
24% and 19% of participants identifying as
Black and Hispanic, respectively. Eighty-two
percent of participants were unemployed,
and 60% reported income below 100% of
the Federal Poverty Level. Most participants
had suppressed viral loads (95%; <50 copies/
mL) with a median CD4+ count of 621 cells/
mm.3 A large majority of respondents had at
least one mental health diagnosis (81%) and
38% reported substance use. Twenty-two
respondents (95%) were on a multiple-pill
regimen taken once daily, and 85% had no
change in their ART medication regimen.
A large majority (71%) were taking an
integrase strand transfer inhibitor-based ART
regimen. Thirty-eight percent of participants
reported having someone at home who helped
them remember to take their medication. A
summary of patient demographics can be
found in Table 1.
The most common reasons for missed doses
identified by participants were “forgetting”
(58 %), and “not feeling like taking the
medicine” (11%) (Figure 1). All participants
reported that the blister packaging program
helped them miss fewer doses of their ART
medication. Similarly, all agreed that they
would recommend the blister packaging
program to others. The most helpful aspect of
the program reported was being able to see
when they had missed a dose (100% reported
this as being “very helpful”). Other helpful
aspects included the medicine being delivered
to their home (90% reported “very helpful”)
and better organization (95% reported “very
helpful”) (Figure 2).

Participant demographics and clinical characteristics.
Characteristic

Median (IQR)
or n (%)

Characteristic

Median (IQR)
or n (%)

Age, years

54 (48, 58)

ART Duration, years

8.7 (4.9, 14.4)

Last Viral Load < 50 copies/mL

20 (95)

Last CD4 cells/mm

621 (398, 976)

Sex assigned at birth
Female

10 (48)

Male

11 (52)

Regimen Anchor Type

Race/Ethnicity
Non-Hispanic White

11 (52)

Non-Hispanic Black

5 (24)

American Indian / Alaska
Native

1 (5)

Hispanic

4 (19)

10 (48)

Married

3 (14)

Significant Other / Life Partner

3 (14)

Divorced

5 (24)

Integrase Inhibitor

15 (71)

Non-nucleotide Reverse
Transcriptase Inhibitor

1 (5)

Protease Inhibitor

5 (24)

ART Pill Count

Marital Status
Single

3

Work Status

1

6 (29)

2

10 (48)

3

3 (14)

5

2 (10)

Total Number of Medications

9 (7, 11)

Mental Health Diagnosis

17 (81)
5 (24)

Employed for wages

4 (19)

History of Opportunistic Infection

Out of work (involuntary)

2 (10)

Diabetes

7 (33)

Out of work (voluntary)

2 (10)

Unable to work

13 (62)

Hypertension

11 (52)

Cardiovascular Disease

13 (62)

Kidney Disease

3 (14)

Substance Use

8 (38)

Income
Below 100% of the federal
poverty level

12 (60)

At least 100% of the federal
poverty level

8 (40)

HIV Duration, years

5%

HIV: Human Immunodeficiency Virus

16.2 (12.2, 21.7)

5%

5%
5%
5%
6%

58%
11%

ART: Antiretroviral Therapy



Didn't want other people to know



Did not like being reminded of my HIV



Too many pills
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Too busy



No way to get to the pharmacy



Just didn't feel like taking the medicine



Forgot

Figure 1. Patient-reported biggest reasons for missed doses of ART (n = 21).

Discussion
In this survey study to evaluate the
perspectives and satisfaction of patients
enrolled in the CCP blister packaging
program, nearly all participants reported high
satisfaction. Many respondents appreciated
being able to see potential missed doses
and all respondents indicated satisfaction
with the program by stating that they would
recommend the program to others. Our
findings that missed doses are often due
Dec. 2020 | Vol. 2 | Issue 2

to forgetfulness and lack of transportation
aligns with other reported common adherence
barriers.10 Patients who participate in this
blister packaging program were enrolled
due to prior issues with non-adherence.
Almost all of the patients in the program who
responded to the survey had controlled viral
loads at the time of the survey, indicating
that the patients were likely having improved

adherence with their ART after enrollment
in the program. An early evaluation of this
blister packaging program cohort showed
that program participants had improved viral
suppression after enrollment.9 The participant
population had a high prevalence of comorbid
conditions, predominantly related to mental
health diagnoses. Despite many participants
being on single-tablet regimens of ART,
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The patients enrolled in the blister packaging
program are a small percentage of the 13001400 patients in the clinic on ART. To study
this process on a larger scale, a multi-center
study involving other community pharmacies
could be useful. Furthermore, a program
like this could have applications outside of
HIV care, for patients followed by primary
care clinicians managing conditions like
hypertension, hyperlipidemia, and diabetes.
Increased adherence has previously been
demonstrated in trials of blister packaging
programs for psychiatric medications and
hypertensive medications.11,12 A study
investigating the use of blister packaging
for multiple medications in elderly patients
showed improvements in blood pressure
and LDL measurements.13 This broader
application could subsequently lead to
improved overall outcomes of our patient
populations, particularly those at risk for more
severe disease. These previous studies looked
only at efficacy of the programs, and further
studies on patient satisfaction may be helpful.
Strengths of this study include the relatively
high response rate for a survey study, with
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